NKF 2012 Spring Meeting Coverage


Follow our archived coverage from the National Kidney Foundation's 2012 Spring Clinical Meetings in Washington, D.C., including our four sections below that were updated with multiple stories daily.



High, Low PTH Raises Hypercalcemia Risk

NATIONAL HARBOR, Md.—Low and high levels of parathyroid hormone (PTH) are associated with hypercalcemia, according to a study of 106,760 hemodialysis patients presented at the National Kidney Foundation 2012 Spring Clinical Meetings suggest.

Novel Formulation Corrects Vitamin D, Lowers iPTH

NATIONAL HARBOR, Md.—An investigational treatment safely and effectively lowers elevated plasma intact parathyroid hormone (iPTH) levels in patients with stage 3 or 4 chronic kidney disease and vitamin D deficiency, researchers reported at the National Kidney Foundation 2012 Spring Clinical Meetings.

Obesity a Barrier to Living Kidney Donation

NATIONAL HARBOR, Md.—Morbid obesity often is a barrier to living kidney donation, researchers reported at the National Kidney Foundation 2012 Spring Clinical Meetings.

Fluid Overload in Burn Patients Affects Survival

NATIONAL HARBOR, Md.—Fluid overload in adult burn patients is associated with increased mortality, data presented at the National Kidney Foundation 2012 Spring Clinical Meetings suggest.

Peginesatide Requirements Do Not Differ By Race

NATIONAL HARBOR, Md.—Black hemodialysis (HD) patients with anemia require relatively more epoetin than their non-black counterparts to achieve similar hemoglobin (Hb) levels, but blacks and non-blacks required similar peginesatide doses, according to findings presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

SHPT Linked to Vitamin D Deficiency in CKD Patients

NATIONAL HARBOR, Md.—Vitamin D deficiency is strongly associated with secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), according to data presented at the National Kidney Foundation (NKF) 2012 Spring Clinical Meetings.

Labs May Vary in iPTH Measurements

NATIONAL HARBOR, Md.—Laboratories can differ in their measurements of intact parathyroid hormone (iPTH) levels, resulting in varying treatment approaches for hemodialysis (HD) patients depending on the iPTH assay used, researchers reported at the National Kidney Foundation Spring Clinical Meetings.

Renal Ultrasound Use for CKD Patients Unchanged Despite Guidelines

NATIONAL HARBOR, Md.—Renal ultrasound use for patients with chronic kidney disease (CKD) has not changed significantly since the release of guidelines in 2002 recommending imaging studies for patients with CKD or who are at risk for it as a result of urinary stones, infections, and other factors.

PCa Patients on HD Would Benefit from Early Kidney Transplantation

NATIONAL HARBOR, Md.—Hemodialysis (HD) patients awaiting a kidney transplant must have a two-year cancer-free period immediately preceding transplantation.

Higher Alkaline Phosphatase Raises Death Risk in HD Patients

NATIONAL HARBOR, Md.—Elevated levels of serum alkaline phosphatase are associated with decreased long-term survival among hemodialysis (HD) patients, data presented at the National Kidney Foundation 2012 Spring Clinical Meetings suggest.

CKD Elevates Risk of Post-Op AKI

NATIONAL HARBOR, Md.—Patients with chronic kidney disease (CKD) before undergoing surgical procedures are at increased risk of acute kidney injury (AKI) post-operatively, researchers reported at the National Kidney Foundation Spring Clinical Meetings.

Rapid Anemia Management May Reduce Hospital Readmission Rates

NATIONAL HARBOR, Md.—Rapid anemia management (RAM) for patients with end-stage renal disease within seven days of hospital discharge decreases their rate of readmission, according to findings presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

Hospitalized ESRD Patients Face Long Hemoglobin Recovery Time

NATIONAL HARBOR, Md.—Nearly two thirds of patients with end-stage renal disease (ESRD) experience a drop in hemoglobin (Hb) level after hospitalization, and it may take months after hospitalization for Hb levels to recover, researchers reported at the National Kidney Foundation 2012 Spring Clinical Meetings.

CKD Patients May Need Higher 25D Levels

NATIONAL HARBOR, Md.—Levels of 25-hydroxyvitamin D (25D) higher than 20 ng/mL would be required to normalize intact parathyroid hormone (iPTH) in patients with stages 3 and 4 chronic kidney disease (CKD) with vitamin D insufficiency and secondary hyperparathyroidism, researchers concluded in a study presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

Calcitriol as Effective as Vitamin D Analogues, but Cheaper

NATIONAL HARBOR, Md.—Oral calcitriol is as effective as vitamin D analogues for treating secondary hyperparathyroidism (SHPT) in hemodialysis patients but is more cost effective, according to a study presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

Sign Up for Free e-newsletters